J Virol. 1992 January; 66(1): 62-69
Methylation of discrete sites within the enhancer region regulates the activity of the Epstein-Barr virus BamHI W promoter in Burkitt lymphoma lines.
A Jansson,
M Masucci and
L Rymo
Department of Clinical Chemistry, Gothenburg University, Sahlgren's Hospital, Sweden.
ABSTRACT
Eight of the nine viral antigens known to be expressed in in vitro Epstein-Barr virus (EBV)-transformed B-lymphoblastoid cell lines are downregulated in EBV-carrying Burkitt lymphomas (BL). Only EBNA1 can be detected in BL biopsies and BL-derived cell lines that maintain the representative phenotype during culture in vitro (group I BL lines). This restricted pattern of viral gene expression is accompanied by extensive EBV DNA methylation and can be reversed by treatment with the demethylating agent 5-azacytidine. Transcription of the genes encoding the six transformation-associated EBNAs can be initiated from one of two promoters located in the BamHI C and W regions, respectively, of the virus genome. We show that discrete sites within the BamHI W enhancer region are methylated in the group I BL lines Rael, Cheptage, and Elijah and become unmethylated after 5-azacytidine treatment that induces the expression of EBNA2. Demethylation correlates with activation of transcription from the BamHI W promoter as determined by S1 protection analysis. Reporter plasmids in which the W enhancer sequences were linked to the chloramphenicol acetyltransferase gene were active in untreated Rael, Cheptage, and Elijah cells, demonstrating that all of the required transcription factors are present in group I BL cells. Conversely, in vitro methylation of the enhancer sequences abolished their activity. The results suggest that methylation of control regions in the EBV genome may play a critical role for the regulation of viral gene expression in tumor cells.
J Virol. 1992 January; 66(1): 62-69
This article has been cited by other articles:
-
Tierney, R., Nagra, J., Hutchings, I., Shannon-Lowe, C., Altmann, M., Hammerschmidt, W., Rickinson, A., Bell, A.
(2007). Epstein-Barr Virus Exploits BSAP/Pax5 To Achieve the B-Cell Specificity of Its Growth-Transforming Program. J. Virol.
81: 10092-10100
[Abstract]
[Full Text]
-
Hutchings, I. A., Tierney, R. J., Kelly, G. L., Stylianou, J., Rickinson, A. B., Bell, A. I.
(2006). Methylation Status of theEpstein-Barr Virus (EBV) BamHI W Latent Cycle Promoter and Promoter Activity: Analysis with Novel EBV-Positive Burkitt and Lymphoblastoid Cell Lines. J. Virol.
80: 10700-10711
[Abstract]
[Full Text]
-
Feng, W.-h., Kenney, S. C.
(2006). Valproic Acid Enhances the Efficacy of Chemotherapy in EBV-Positive Tumors by Increasing Lytic Viral Gene Expression.. Cancer Res.
66: 8762-8769
[Abstract]
[Full Text]
-
Bhende, P. M., Seaman, W. T., Delecluse, H.-J., Kenney, S. C.
(2005). BZLF1 Activation of the Methylated Form of the BRLF1 Immediate-Early Promoter Is Regulated by BZLF1 Residue 186. J. Virol.
79: 7338-7348
[Abstract]
[Full Text]
-
Elliott, J., Goodhew, E. B., Krug, L. T., Shakhnovsky, N., Yoo, L., Speck, S. H.
(2004). Variable Methylation of the Epstein-Barr Virus Wp EBNA Gene Promoter in B-Lymphoblastoid Cell Lines. J. Virol.
78: 14062-14065
[Abstract]
[Full Text]
-
Chau, C. M., Lieberman, P. M.
(2004). Dynamic Chromatin Boundaries Delineate a Latency Control Region of Epstein-Barr Virus. J. Virol.
78: 12308-12319
[Abstract]
[Full Text]
-
Dufva, M., Flodin, J., Nerstedt, A., Ruetschi, U., Rymo, L.
(2002). Epstein-Barr virus nuclear antigen 5 inhibits pre-mRNA cleavage and polyadenylation. Nucleic Acids Res
30: 2131-2143
[Abstract]
[Full Text]
-
Moore, S. M., Cannon, J. S., Tanhehco, Y. C., Hamzeh, F. M., Ambinder, R. F.
(2001). Induction of Epstein-Barr Virus Kinases To Sensitize Tumor Cells to Nucleoside Analogues. Antimicrob. Agents Chemother.
45: 2082-2091
[Abstract]
[Full Text]
-
Nilsson, T., Zetterberg, H., Wang, Y. C., Rymo, L.
(2001). Promoter-Proximal Regulatory Elements Involved in oriP-EBNA1-Independent and -Dependent Activation of the Epstein-Barr Virus C Promoter in B-Lymphoid Cell Lines. J. Virol.
75: 5796-5811
[Abstract]
[Full Text]
-
Tierney, R., Kirby, H., Nagra, J., Rickinson, A., Bell, A.
(2000). The Epstein-Barr Virus Promoter Initiating B-Cell Transformation Is Activated by RFX Proteins and the B-Cell-Specific Activator Protein BSAP/Pax5. J. Virol.
74: 10458-10467
[Abstract]
[Full Text]
-
Tierney, R. J., Kirby, H. E., Nagra, J. K., Desmond, J., Bell, A. I., Rickinson, A. B.
(2000). Methylation of Transcription Factor Binding Sites in the Epstein-Barr Virus Latent Cycle Promoter Wp Coincides with Promoter Down-Regulation during Virus-Induced B-Cell Transformation. J. Virol.
74: 10468-10479
[Abstract]
[Full Text]
-
Kirby, H., Rickinson, A., Bell, A.
(2000). The activity of the Epstein-Barr virus BamHI W promoter in B cells is dependent on the binding of CREB/ATF factors. J. Gen. Virol.
81: 1057-1066
[Abstract]
[Full Text]
-
Paulson, E. J., Speck, S. H.
(1999). Differential Methylation of Epstein-Barr Virus Latency Promoters Facilitates Viral Persistence in Healthy Seropositive Individuals. J. Virol.
73: 9959-9968
[Abstract]
[Full Text]
-
Zetterberg, H, Stenglein, M, Jansson, A, Ricksten, A, Rymo, L
(1999). Relative levels of EBNA1 gene transcripts from the C/W, F and Q promoters in Epstein-Barr virus-transformed lymphoid cells in latent and lytic stages of infection. J. Gen. Virol.
80: 457-466
[Abstract]
-
Tao, Q., Robertson, K. D., Manns, A., Hildesheim, A., Ambinder, R. F.
(1998). The Epstein-Barr Virus Major Latent Promoter Qp Is Constitutively Active, Hypomethylated, and Methylation Sensitive. J. Virol.
72: 7075-7083
[Abstract]
[Full Text]
-
Tao, Q., Robertson, K. D., Manns, A., Hildesheim, A., Ambinder, R. F.
(1998). Epstein-Barr Virus (EBV) in Endemic Burkitt's Lymphoma: Molecular Analysis of Primary Tumor Tissue. Blood
91: 1373-1381
[Abstract]
[Full Text]
Copyright © 1992 by the American Society for Microbiology. All rights reserved.